Tech Company Financing Transactions
Risalto Health Funding Round
Risalto Health closed a $7 million funding round on 11/14/2019. Investors included Health Catalyst Capital Management and Oxeon Ventures.
Transaction Overview
Company Name
Announced On
11/14/2019
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to scale its program nationwide and drive platform enhancements.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
600 5th Ave. 2nd Floor
New York, NY 10020
USA
New York, NY 10020
USA
Phone
Undisclosed
Website
Email Address
Overview
Launched with the backing of Oxeon Partners in 2016, Risalto aimed to bring the most effective care to every patient. In order to accomplish this, it was clear that we couldn't just create another digital health solution, we had to rethink everything from how a member becomes a patient, to that patient's relationship with their provider universe.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Pizzarello
Chief Medical Officer
David Jevsevar
President
Randy Hutchinson
VP - Bus. Development
Nancy Powers
VP - Engineering
Sam Brochot
VP - Product Management
Allison Schoeneck
Browse more venture capital transactions:
Prev: 11/14/2019: Avidity Biosciences venture capital transaction
Next: 11/14/2019: Cutover venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs